TickerFactsScreenerDevelopers

Protara Therapeutics, Inc. (TARA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$17.57M2016: -$23.69M2017: -$22.35M2018: -$23.23M2019: -$5.01M2020: -$23.41M2021: -$34.50M2022: -$26.46M2023: -$37.56M2024: -$35.81M2025: -$56.37M-$56.37M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$56.37M-57.4%
2024-$35.81M+4.7%
2023-$37.56M-42.0%
2022-$26.46M+23.3%
2021-$34.50M-47.4%
2020-$23.41M-367.1%
2019-$5.01M+78.4%
2018-$23.23M-3.9%
2017-$22.35M+5.6%
2016-$23.69M-34.8%
2015-$17.57M—